2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty

Purpose: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery...

Full description

Bibliographic Details
Main Authors: Kirsten A. Gunderson, BS, Armin Edalatpour, MD, Peter Wirth, MD, Katherine Rose, MD, Katherine M. Gast, MD, MS
Format: Article
Language:English
Published: Wolters Kluwer 2021-07-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000770144.39567.ee
_version_ 1819141909546795008
author Kirsten A. Gunderson, BS
Armin Edalatpour, MD
Peter Wirth, MD
Katherine Rose, MD
Katherine M. Gast, MD, MS
author_facet Kirsten A. Gunderson, BS
Armin Edalatpour, MD
Peter Wirth, MD
Katherine Rose, MD
Katherine M. Gast, MD, MS
author_sort Kirsten A. Gunderson, BS
collection DOAJ
description Purpose: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery. Methods: Retrospective chart review was performed on patients undergoing PIV from February 2018 through March 2020 by the senior author (K.G.) at the University of Wisconsin Hospital and Clinics. Patients who received TXA received a combination of topical and intravenous TXA. Data collected includes patient demographics (age, body mass index, race, comorbidities, and tobacco and illicit drug use), intraoperative data (duration of surgery, estimated blood loss, fluid administration, TXA use and dose, and complications), and postoperative data (drain output, complications within 30 days, and revision surgery). Subgroup analysis on the effect of TXA was performed using independent sample t-test. Results: Seventy-four patients were included in this study with 56 patients receiving TXA and 18 patients who had surgery prior to initiation of TXA protocol. There were no thromboembolic events observed in the TXA or the non-TXA group. Ninety percent of all complications were Clavien-Dindo Grade 1 and did not require intervention. There was a significantly lower EBL in the TXA group compared to the no TXA cohort (299.1 ± 64.3 vs. 347.2 ± 84.8, p=0.013). Patients who received TXA had significantly fewer wound related complications than those who did not receive TXA (21.4% vs. 66.7%, p<0.0001). Similarly, there were fewer neo-vagina skin graft failures in the TXA group, though this did not reach significance (0.0% vs. 11.1%, p=0.057). There was no significant difference in drain output between the two groups. Conclusion: No thromboembolic events were observed with intravenous and topical tranexamic acid use in transfeminine patients undergoing penile inversion vaginoplasty surgery. TXA was also associated with lower intraoperative blood loss as well as fewer wound healing complications. Further research is needed to further study its use in gender affirmation surgery.
first_indexed 2024-12-22T12:01:57Z
format Article
id doaj.art-cc7d5155754f4347b1eb795a62a09846
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-12-22T12:01:57Z
publishDate 2021-07-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-cc7d5155754f4347b1eb795a62a098462022-12-21T18:26:34ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742021-07-0197S394010.1097/01.GOX.0000770144.39567.ee202107001-000562: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion VaginoplastyKirsten A. Gunderson, BS0Armin Edalatpour, MD1Peter Wirth, MD2Katherine Rose, MD3Katherine M. Gast, MD, MS4University of Wisconsin School of Medicine and Public Health, Division of Plastic Surgery, Madison, WI, USA.University of Wisconsin School of Medicine and Public Health, Division of Plastic Surgery, Madison, WI, USA.University of Wisconsin School of Medicine and Public Health, Division of Plastic Surgery, Madison, WI, USA.University of Wisconsin School of Medicine and Public Health, Division of Plastic Surgery, Madison, WI, USA.University of Wisconsin School of Medicine and Public Health, Division of Plastic Surgery, Madison, WI, USA.Purpose: Penile inversion vaginoplasty (PIV) is the most common gender affirming genital procedure for transfeminine patients. The purpose of this study was to investigate the impact of tranexamic acid (TXA), an antifibrinolytic, on bleeding and bleeding-related complications in vaginoplasty surgery. Methods: Retrospective chart review was performed on patients undergoing PIV from February 2018 through March 2020 by the senior author (K.G.) at the University of Wisconsin Hospital and Clinics. Patients who received TXA received a combination of topical and intravenous TXA. Data collected includes patient demographics (age, body mass index, race, comorbidities, and tobacco and illicit drug use), intraoperative data (duration of surgery, estimated blood loss, fluid administration, TXA use and dose, and complications), and postoperative data (drain output, complications within 30 days, and revision surgery). Subgroup analysis on the effect of TXA was performed using independent sample t-test. Results: Seventy-four patients were included in this study with 56 patients receiving TXA and 18 patients who had surgery prior to initiation of TXA protocol. There were no thromboembolic events observed in the TXA or the non-TXA group. Ninety percent of all complications were Clavien-Dindo Grade 1 and did not require intervention. There was a significantly lower EBL in the TXA group compared to the no TXA cohort (299.1 ± 64.3 vs. 347.2 ± 84.8, p=0.013). Patients who received TXA had significantly fewer wound related complications than those who did not receive TXA (21.4% vs. 66.7%, p<0.0001). Similarly, there were fewer neo-vagina skin graft failures in the TXA group, though this did not reach significance (0.0% vs. 11.1%, p=0.057). There was no significant difference in drain output between the two groups. Conclusion: No thromboembolic events were observed with intravenous and topical tranexamic acid use in transfeminine patients undergoing penile inversion vaginoplasty surgery. TXA was also associated with lower intraoperative blood loss as well as fewer wound healing complications. Further research is needed to further study its use in gender affirmation surgery.http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000770144.39567.ee
spellingShingle Kirsten A. Gunderson, BS
Armin Edalatpour, MD
Peter Wirth, MD
Katherine Rose, MD
Katherine M. Gast, MD, MS
2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
Plastic and Reconstructive Surgery, Global Open
title 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_full 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_fullStr 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_full_unstemmed 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_short 2: Tranexamic Acid Is Associated With Decreased Intraoperative Blood Loss And Wound Healing Complication Rate In Penile Inversion Vaginoplasty
title_sort 2 tranexamic acid is associated with decreased intraoperative blood loss and wound healing complication rate in penile inversion vaginoplasty
url http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000770144.39567.ee
work_keys_str_mv AT kirstenagundersonbs 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT arminedalatpourmd 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT peterwirthmd 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT katherinerosemd 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty
AT katherinemgastmdms 2tranexamicacidisassociatedwithdecreasedintraoperativebloodlossandwoundhealingcomplicationrateinpenileinversionvaginoplasty